HAIC Combined Sintilimab for Liver Metastasis From Esophageal Squamous Cell Carcinoma
Conditions
- Hepatic Arterial Infusion Chemotherapy
- Liver Metastases
- Esophageal Squamous Cell Carcinoma
Interventions
- DRUG: HAIC combined with intravenous PD-1
Sponsor
Peking University Cancer Hospital & Institute
Collaborators